Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1–August 20, 2021): a retrospective observational monocentric study

BACKGROUND: Monoclonal antibodies (mAb) prevent COVID-19 progression when administered early. We compared mAb treatment outcomes among vaccinated and unvaccinated patients during Delta wave and assessed the feasibility of implementing stricter eligibility criteria in the event of mAb scarcity. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yi, Cowman, Kelsie, Chang, Mei, Bao, Hongkai, Golia, Austin, Mcsweeney, Terrence, Bard, Linda, Simpson, Roxanne, Andrews, Erin, Pirofski, Liise-anne, Nori, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325951/
https://www.ncbi.nlm.nih.gov/pubmed/35896965
http://dx.doi.org/10.1186/s12879-022-07626-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325951/
https://www.ncbi.nlm.nih.gov/pubmed/35896965
http://dx.doi.org/10.1186/s12879-022-07626-6

Ejemplares similares